Efficacy and safety of zidovudine, lamivudine, and tenofovir combination in antiretroviral naive, HIV-1 infected patients

被引：0
|
作者：
Rey, D [1 ]
Krebs, M [1 ]
Partisani, M [1 ]
Hess-Kempf, G [1 ]
Cheneau, C [1 ]
Priester, M [1 ]
Bernard-Henry, C [1 ]
De Mautort, E [1 ]
Lang, JM [1 ]
机构：
[1] Hop Univ, CISIH Clin Med A, Strasbourg, France
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2004年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [1] The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naive HIV-1-infected patients
    Cassetti, Isabel
    Madruga, Jose Valdez R.
    Suleiman, Jamal Muhamad A. H.
    Etzel, Arnaldo
    Zhong, Lijie
    Cheng, Andrew K.
    Enejosa, Jeffrey
    [J]. HIV CLINICAL TRIALS, 2007, 8 (03): : 164 - 172
  • [2] Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults
    Goodgame, JC
    Pottage, JC
    Jablonowski, H
    Hardy, WD
    Stein, A
    Fischl, M
    Morrow, P
    Feinberg, J
    Brothers, CH
    Vafidis, I
    Nacci, P
    Yeo, J
    Pedneault, L
    [J]. ANTIVIRAL THERAPY, 2000, 5 (03) : 215 - 225
  • [3] Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients
    Masquelier, Bernard
    Neau, Didier
    Boucher, Sebastien
    Lavignolle-Aurillac, Valerie
    Schrive, Marie-Helene
    Recordon-Pinson, Patricia
    Ragnaud, Jean-Marie
    Fleury, Herve
    [J]. ANTIVIRAL THERAPY, 2006, 11 (06) : 827 - 830
  • [4] Cost-efectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-Infected patients
    Sanchez-de la Rosa, Rainel
    Herrera, Luis
    Moreno, Santiago
    [J]. CLINICAL THERAPEUTICS, 2008, 30 (02) : 372 - 381
  • [5] Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients - A randomized controlled comparison with zidovudine monotherapy
    Katlama, C
    Ingrand, D
    Loveday, C
    Clumeck, N
    Mallolas, J
    Staszewski, S
    Johnson, M
    Hill, AM
    Pearce, G
    McDade, H
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02): : 118 - 125
  • [6] A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience
    Haubrich, R
    Thompson, M
    Schooley, R
    Lang, W
    Stein, A
    Sereni, D
    van der Ende, ME
    Antunes, F
    Richman, D
    Pagano, G
    Kahl, L
    Fetter, A
    Brown, DJ
    Clumeck, N
    [J]. AIDS, 1999, 13 (17) : 2411 - 2420
  • [7] Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in anti retroviral-naive HIV-1-infected patients
    Rey, David
    Krebs, Magali
    Partisani, Marialuisa
    Hess, Georgette
    Cheneau, Christine
    Priester, Michele
    Bernard-Henry, Claudine
    de Mautort, Erik
    Lang, Jean-Marie
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (05) : 530 - 534
  • [8] Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe
    Swartz, J. E.
    Vandekerckhove, L.
    Ammerlaan, H.
    de Vries, A. C.
    Begovac, J.
    Bierman, W. F. W.
    Boucher, C. A. B.
    van der Ende, M. E.
    Grossman, Z.
    Kaiser, R.
    Levy, I.
    Mudrikova, T.
    Paredes, R.
    Perez-Bercoff, D.
    Pronk, M.
    Richter, C.
    Schmit, J. C.
    Vercauteren, J.
    Zazzi, M.
    Lepej, S. Zidovec
    De Luca, A.
    Wensing, A. M. J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (06) : 1850 - 1857
  • [9] AVANTI 1: randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus loviride in HIV-infected antiretroviral-naive patients
    Gatell, J
    Lange, J
    Gartland, M
    [J]. ANTIVIRAL THERAPY, 1999, 4 (02) : 79 - 86
  • [10] Twenty-four-week efficacy and resistance profile of a zidovudine/lamivudine/tenofovir DF combination therapy in antiretroviral-naive patients
    Masquelier, B
    Neau, D
    Boucher, S
    Lavignolle-Aurillac, V
    Schrive, MH
    Recordon-Pinson, P
    Ragnaud, JM
    Fleury, H
    [J]. ANTIVIRAL THERAPY, 2005, 10 : S22 - S22
12345